You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海泰新光(688677.SH):擬出資7840萬元與國藥器械設立合資公司
格隆匯 01-10 16:42

格隆匯1月10日丨海泰新光(688677.SH)公佈,公司擬與中國醫療器械有限公司(“國藥器械”)設立合資公司。合資公司註冊資本為人民幣1.6億元,其中海泰新光以貨幣出資7840萬元,佔註冊資本總額的49%,國藥器械以貨幣出資8160萬元,佔註冊資本總額的51%。

合資公司將以醫用內窺鏡整機系統為切入點,瞄準中國醫用內窺鏡市場,建立自主品牌,迅速實現取證和銷售,逐步在中國市場佔有一定的市場份額,並同步啟動下一代技術和產品的研發和迭代,包括3D、人工智能以及其他微創外科技術和產品,打造國產醫用內窺鏡整機和微創外科領域領先企業。本次投資完成後,合資公司將成為公司的參股子公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account